Angiogenin (ANG), originally identified as an angiogenic ribonuclease, has recently been shown to play a direct role in prostate cancer cell proliferation by mediating rRNA transcription. ANG is up-regulated in human prostate cancer and is the most significantly up-regulated gene in AKT-driven prostate intraepithelial neoplasia (PIN) in mice. Enhanced cell proliferation in the PIN lesions requires increased ribosome biogenesis, a multistep process involving an orchestrated production of ribosomal proteins and rRNA. AKT is known to enhance ribosomal protein production through the mammalian target of rapamycin pathway. However, it was unknown how rRNA is proportionally increased. Here, we report that ANG is essential for AKT-driven PIN formation and survival. We showed that up-regulation of ANG in the AKT-overexpressing mouse prostates is an early and lasting event. It occurs before PIN initiation and lasts beyond PIN is fully developed. Knocking down ANG expression by intraprostate injection of lentivirus-mediated ANG-specific small interfering RNA prevents AKT-induced PIN formation without affecting AKT expression and its signaling through the mammalian target of rapamycin pathway. Neomycin, an aminoglycoside that blocks nuclear translocation of ANG, and N65828, a small-molecule enzymatic inhibitor of the ribonucleolytic activity of ANG, both prevent AKT-induced PIN formation and reverse established PIN. They also decrease nucleolar organizer region, restore cell size, and normalize luminal architectures of the prostate despite continuous activation of AKT. All three types of the ANG inhibitor suppress rRNA transcription of the prostate luminal epithelial cells and inhibit AKT-induced PIN, indicating an essential role of ANG in AKT-mediated cell proliferation and survival.
Introduction
Angiogenin (ANG) is a 14-kDa ribonuclease originally identified as an angiogenic protein (1) that has been shown to play an important role in tumor angiogenesis (2, 3) . ANG undergoes nuclear translocation in endothelial cells where it stimulates rRNA transcription (4, 5) . Recently, ANG has been shown to be progressively up-regulated in prostate cancer (6) (7) (8) and to play a direct role in cancer cell proliferation by constitutive nuclear translocation in cancer cells where it also stimulates rRNA transcription (8, 9) . Knocking down ANG expression in PC-3 human prostate cancer cells decreases rRNA transcription, ribosome biogenesis, cell proliferation, and tumorigenicity in a xenograft athymic mouse model (8) . rRNA transcription is essential for ribosome biogenesis, protein translation, and therefore cell growth and proliferation (10) . Abnormal ribosomal biogenesis has been shown to be associated with cancer pathogenesis (11) . Therefore, ANG has been proposed to play a dual role in prostate cancer progression by stimulating both angiogenesis and cancer cell proliferation (8) . However, because these observations were from studies of cell culture and xenograft tumor models, it is unknown whether ANG plays a role in prostate cancer initiation from its orthotopic origins and whether it is involved in prostate cancer progression in the natural environment.
Mouse ANG is the most significantly up-regulated gene in the prostate during prostate intraepithelial neoplasia (PIN) development in murine prostate-restricted AKT transgenic (MPAKT) mice (7) . In these mice, expression of AKT in the ventral prostate results in activation of the p70 S6K pathway and induction of PIN similar in character to that observed in PTEN +/À mice (12) . PTEN has been shown to regulate cell size in association with its ability to regulate ribosome biogenesis (13, 14) . PTEN is a phosphatase that down-regulates the phosphatidylinositol 3-kinase pathway by dephosphorylating the lipid phosphotidylinositol-3,4,5-trisphosphate to phosphotidylinositol-4,5-bisphosphate (15, 16) . Inactivating somatic mutation of PTEN or loss of the PTEN protein is common in prostate cancer cell lines and in primary and metastatic tumor specimens (17) (18) (19) . Mutation of PTEN leads to deregulated phosphatidylinositol 3-kinase signaling, resulting in constitutive activation of downstream targets including the AKT kinase family. AKT kinase activity is frequently elevated in prostate cancers (20) . AKT is activated through phosphorylation on Ser 473 and Thr 308 . Activated AKT promotes both cell growth and cell survival.
Mammalian target of rapamycin (mTOR) plays an important role in phosphatidylinositol 3-kinase-and AKTdependent oncogenesis, especially in the pathogenesis of prostate cancer (7, 21) . Transformation by phosphatidylinositol 3-kinase or AKT directly correlates with activation of mTOR and its downstream target S6K (22) . S6 phosphorylation has been associated with translation of a specific class of mRNA termed TOP (a terminal oligopyrimidine track in the 5 ¶-untranslated region) mRNA (23) . This class of mRNAs includes ribosomal proteins, elongation factors 1A1 and 1A2, and several other proteins involved in ribosome biogenesis or in translation control (24) . Thus, AKT activation will enhance ribosomal protein production. However, a missing link from AKT overexpression to enhanced ribosome biogenesis is how transcription of rRNA, which needs to be incorporated in an equimolar ratio, is proportionally elevated. We tested the hypothesis that ANG is up-regulated in the prostate of MPAKT mice to fulfill this growth requirement. Our results show that inhibition of ANG expression and/or activities by various mechanisms prevents and reverses PIN in MPAKT mice accompanied with suppression of rRNA transcription but without affecting AKT phosphorylation.
Results

Up-Regulation of ANG Expression in AKT-Driven PIN Is an Early and Lasting Event
Mouse ANG is the highest up-regulated gene in the PIN lesion in MPAKT mice (7) . However, the role of ANG in the development and maintenance of PIN was unknown (7). It was also unknown when up-regulation of ANG starts and how long it lasts. We therefore first used immunohistochemistry with an affinity-purified anti-mouse ANG polyclonal antibody (R163) to show that the ANG protein levels are higher in the ventral prostate of MPAKT mice than in that of the wild-type (WT) littermates across the age ranging from 4 to 12 weeks (Fig. 1A) . R163 has been used previously to detect mouse ANG expression during development and has been shown to be specific to mouse ANG. No immunohistochemical signals were detected if the primary antibody was omitted or if the incubation was carried out in the presence of mouse ANG protein (1 Ag/mL). Therefore, up-regulation of ANG in the prostate of MPAKT mice is an early and lasting event. Because it is known that PIN starts to develop at week 6 in MPAKT mice and has been fully developed at week 12 (7), these results suggest that ANG may play a role in PIN initiation as well as the survival and maintenance of established PIN in these mice. ANG was detected in the extracellular matrix (white arrows), consistent with its established role in stimulating angiogenesis. Strong nuclear staining of ANG was observed in the prostate luminal epithelial cells of MPAKT mice (Fig. 1A , black arrows). More importantly, higher magnification images revealed prominent nucleolar accumulation of ANG (Fig. 1B,  arrows) , suggesting that ANG plays a role in ribosome biogenesis, growth, and proliferation of prostate luminal epithelial cells.
Knocking Down ANG Expression Prevented PIN Formation
To understand the role of ANG in original cell growth and proliferation in the PIN lesion, we examined the effect of knocking down ANG expression on PIN formation. Mouse ANG1 is the predominant form among the six isoforms and is the orthologue of human ANG (human has only 1 ANG gene; ref. 25) . ANG1 (hereafter labeled as ANG) was therefore targeted with a lentivirus-based small interfering RNA (siRNA) method (26) . Lentiviral vector-mediated mouse ANG-specific siRNA targeting at different regions of the ANG mRNA were obtained form Open Biosystems and their efficacy in knocking down ANG expression was determined in Lewis lung carcinoma cells by reverse transcription-PCR ( Fig. 2A, left) , and confirmed by real-time quantitative reverse transcription-PCR ( Fig. 2A, right) . Four-week-old mice were treated by a single intraprostate injection of lentivirus containing ANGspecific siRNA and a nonspecific control short hairpin RNA (shRNA). Mice were sacrificed at age 8 weeks and examined for PIN formation by H&E staining (Fig. 2B-D) . PIN was formed in mice that were treated with the control shRNA (Fig. 2B) . However, in mice treated with ANG-specific siRNA, PIN formation was inhibited (Fig. 2C) . The percentage of the glands having PIN decreased from 52 F 12% to 16 F 9%, indicating a 64% inhibition. ANG expression was examined by immunohistochemistry with anti-ANG antibody R163 (Fig. 2E-G) . Prominent nuclear ANG protein staining was detected in the ventral prostate epithelial cells of the MPAKT mice treated with control shRNA (Fig. 2E) , which was markedly decreased after treatment with ANG-specific siRNA (Fig. 2F ). The glandular structure and ANG expression level in ANG siRNA-treated prostate ( Fig. 2C and F) were not significantly different from that of the WT littermates ( Fig. 2D and G) . It is notable that, in the ANG siRNA-treated ventral prostates, ANG protein level was higher in f20% PINborn glands than in the PIN-free glands, indicating that ANG expression is inversely correlated to PIN formation in these animals. Thus, ANG-specific siRNA successfully knocked down ANG expression and prevented PIN formation in MPAKT mice, indicating an essential role of ANG in AKTinduced prostate luminal epithelial cell proliferation and PIN formation.
Knocking Down ANG Expression Did Not Inhibit AKT Activity
It is known that AKT overexpression in the prostate of MPAKT mice induces PIN formation through the mTOR-S6K-S6P signaling pathway (7, 21) . To know whether ANG siRNAmediated inhibition of PIN formation was a result of diminished AKT transgene expression or interrupted signal transduction pathway from AKT to S6P, phosphorylation status of AKT and S6P in the prostate luminal epithelial cells was examined by immunohistochemistry. Staining with a p-AKT-specific antibody showed no difference in AKT phosphorylation between control shRNA-treated and ANG siRNA-treated prostates ( Fig. 2H and I ), indicating that AKT transgene expression and phosphorylation were not affected by ANG siRNA. Ribosomal protein S6 (S6RP) is a downstream target of AKT and its phosphorylation is known to enhance ribosomal protein production (27) . Immunohistochemistry with an anti-p-S6RP antibody showed that S6RP phosphorylation was not inhibited by ANG siRNA (Fig. 2K and L) , confirming that the signal transduction pathway of AKT-S6K-S6RP was not affected. Together, these results showed that down-regulation of ANG expression did not inhibit AKT transgene expression and did not affect signaling transduction from AKT to S6P. Thus, ribosomal protein production was not affected by ANG siRNA.
Knocking Down ANG Expression Inhibited rRNA Transcription
Next, we examined ANG siRNA-induced changes in rRNA transcription in the prostate luminal epithelial cells of MPAKT mice. In situ hybridization (ISH) with a probe specific to the initiation site of 47S rRNA showed that rRNA transcription was dramatically increased in the prostate luminal epithelial cells of MPAKT mice (Fig. 2N ) compared with that of the WT littermates (Fig. 2P) . Knocking down ANG expression completely abolished AKT-induced increase in rRNA transcription (Fig. 2O) , suggesting that rRNA transcription in AKTinduced PIN is mediated by ANG.
rRNA transcription is essential for ribosome biogenesis (28, 29) . To confirm that ribosome biogenesis was indeed decreased after ANG expression was knocked down, we examined the effect of ANG siRNA on nucleolar organizer region (NOR) of the prostate epithelial cells. NOR are loops of rDNA that are actively being transcribed (30) . NOR are associated with argyrophilic proteins and can be visualized by silver staining. Both the numbers and the size of the NOR reflect the degree of ribosome biogenesis (31) . Figure 3A shows that treatment of ANG-specific siRNA decreased the average number of NOR per cell from 2.83 to 1.52, indicating a significant decrease in ribosome biogenesis. A slowdown in ribosome biogenesis will result in a decrease in both cell growth and proliferation. Consistent with the suppression of rRNA transcription, knocking down ANG expression decreased cell size as well as cell proliferation. The diameters of the prostate luminal epithelial cells from MPAKT mice treated with the control shRNA and ANG-specific siRNA and that from the WT animals are 15 F 2, 10 F 2, and 10 F 1 Am, respectively (Fig. 3B) . Treatment with ANG siRNA also decreased Ki-67-positive cells from 57.2 F 4.9% to 20.8 F 11.7% (Fig. 3C) . Together, these results showed that knocking down ANG expression suppressed rRNA transcription, thereby inhibiting cell growth and proliferation and preventing PIN formation.
Prevention of PIN Formation by Small-Molecule ANG Inhibitors
Next, we examined the effect of neomycin and 8-amino-5-(4 ¶-hydroxybiphenyl-4-ylazo)naphthalene-2-sulfonate (N65828), two small-molecule inhibitors that abolish ANG activity by different mechanisms, on AKT-induced PIN formation. Previous results have shown that both nuclear translocation of ANG and ribonucleolytic activity of ANG are essential for its biological activity (5, 32) . Nuclear translocation of ANG can be blocked by aminoglycoside antibiotic neomycin (4), whereas the ribonucleolytic activity of ANG can be inhibited by National Cancer Institute compound N65828 (33) . ANG has a unique ribonucleolytic activity that is several orders of magnitude lower than that of the pancreatic RNase A (32) . Extensive studies on site-directed mutagenesis have shown that ANG variants with reduced enzymatic activity also have reduced angiogenic activity (34) (35) (36) (37) (38) (39) (40) . Thus, both neomycin and N65828 have been shown to inhibit xenograft growth of PC-3 human prostate cancer cells in nude mice (8, 33) . These two molecules were used here to examine the effect of ANG inhibition on AKT-driven PIN formation. Treatment with neomycin and N65828 both prevented PIN formation (Fig. 4A-C) but accompanied with a different pattern of nuclear translocation of ANG (Fig. 4D-F) . Under neomycin treatment, the localization of ANG was extracellular (Fig. 4E) , consistent with neomycin being a nuclear translocation blocker. However, ANG remained strongly in the nucleus in N65828-treated specimen (Fig. 4F) . In both cases, AKT phosphorylation ( Fig. 4G-I) was not altered. However, 47S rRNA transcription was inhibited as shown by ISH (Fig. 4J-L) . The mechanism by which N65828 suppresses rRNA transcription is not clear at present. One possibility is that the ribonucleolytic activity of ANG is involved in pre-rRNA processing and its inhibition by N65828 will result in a negative feedback of rRNA transcription. Although such a negative feedback mechanism has been described for other RNA polymerase I-dependent RNase activities (41, 42) , it is unknown whether it is applicable to ANG before we firmly establish that ANG plays a role in rRNA processing. Nevertheless, we have shown that three different types of ANG inhibitors (ANG-specific siRNA, neomycin, and N65828) all prevented AKT-driven PIN formation. In all three cases, rRNA transcription was inhibited but AKT phosphorylation was not affected.
ANG Inhibitors Reversed Established PIN
Up-regulation of ANG in the PIN of MPAKT mice is a lasting event (Fig. 1A) , suggesting that ANG is important not only for the initial cell proliferation that leads to PIN formation but also for cell survival in the established PIN. To determine whether ANG inhibition reverses PIN, 12-week-old MPAKT mice with fully developed PIN were treated with neomycin or N65828 for 4 weeks. Gross examination of the genitourinary tracts showed that the size of the ventral prostate decreased after neomycin treatment (Fig. 5A) . The sizes of the ventral prostates of a representative mouse from the control and neomycintreated groups were 69.8 and 44.3 mm 3 , respectively, indicating shrinkage of the PIN after neomycin treatment. Neomycin treatment also restored cell size to normal (Fig. 5B) . H&E staining showed that the PIN phenotype (Fig. 6A-C) was reversed after both neomycin and N65828 treatments. AKT phosphorylation (Fig. 6D-F ) in both treated groups was not different from that of the control group. However, 47S rRNA level ( Fig. 6G-I ) was dramatically decreased in both neomycinand N65828-treated animals, indicating suppression of rRNA transcription. Apoptosis of the prostate luminal cells would have to occur for a phenotypic reversal of the established PIN. This was indeed the case as shown by TUNEL staining (Fig. 6J-L) . Apoptotic index in the control, neomycin-treated, and N65828-treated prostate was 0.95 F 0.11, 1.95 F 0.19, and 2.02 F 0.21 (caspase-3-positive cells per duct), respectively. These results suggested that ANG inhibitors reversed the established PIN probably due to an inhibition of rRNA transcription that eventually led to cell apoptosis.
Actinomycin D Inhibited PIN in MPAKT Mice
Actinomycin D is a cyclic polypeptide-containing antibiotic that binds to DNA and inhibits RNA synthesis. It interferes with the elongation of growing RNA chains catalyzed by RNA polymerases and is particularly sensitive to that mediated by RNA polymerase I (43) . Therefore, at low concentration, actinomycin D selectively suppresses rRNA transcription (44) . To confirm that increased rRNA transcription is functionally relevant to AKT-induced PIN, we treated 12-week-old MPAKT mice with daily intraperitoneal injection of 0.1 mg/kg body weight for 4 weeks. H&E staining showed that an average of 47 F 9% glands had PIN in control group (Fig. 7A and C) but only 14 F 7% of the glands had PIN in actinomycin-treated group (Fig. 7B and C) , indicating that actinomycin D reversed the PIN phenotype in these animals. ANG expression (Fig. 7D and E) and AKT phosphorylation (Fig. 7F and G) were not altered by treatment of actinomycin D, but rRNA transcription was markedly decreased in treated animals (Fig. 7I ) compared with the untreated ones (Fig. 7H ).
Discussion
The angiogenic activity of ANG has been well established (1, 45) . Biochemical and cell biological studies have shown that the angiogenic activity of ANG is related to its ability to stimulate rRNA transcription (46, 47) , which relies on translocation of ANG to the nucleus and exertion of its ribonucleolytic activity presumably in the nucleolus (48) . ANG antagonists including its monoclonal antibody (2), a soluble binding protein (2) , antisense oligos (3), a nuclear translocation blocker (8) , and an enzymatic inhibitor (33) have all been shown to inhibit xenograft growth of human tumor cells in athymic mice. However, the role of ANG in the growth and progression of tumors arising in a more nature environment has not been studied.
AKT overexpression in the murine prostate induces PIN, accompanied by a dramatic increase of ANG expression (7), which provides a suitable experimental model for us to study the role of ANG in prostate cancer initiation and progression in the orthotopic site. We took an approach combining siRNA and small-molecule inhibitors to examine the effect of ANG inhibition on AKT-induced PIN formation and survival. First, we injected lentivirus-mediated ANG-specific siRNA into the prostate of MPAKT mice and showed that this approach knocked down ANG expression in the prostate and prevented PIN formation. We have also shown that knocking down prostatic expression of ANG suppressed rRNA transcription and cell proliferation. However, phosphorylation of AKT and S6RP, a well-defined downstream target of AKT involved in ribosomal protein production (27) , was not affected by manipulating ANG expression. The finding that ANG siRNA prevented PIN formation, despite continuous expression of AKT transgene and activation of its downstream targets, showed that proliferation and growth of the prostate intraluminal cells driven by AKT requires the participation of ANG. These results suggest that upregulation of ANG stimulates transcription of rRNA that, together with the ribosomal proteins enhanced through the AKT-mTOR-S6K-S6P pathway, allows ribosome biogenesis to take place (Fig. 8) . In other words, both ANG-mediated rRNA and mTOR-mediated ribosomal proteins are required for AKT-induced PIN formation.
It is of interest to note that local inhibition of ANG expression within the prostate was sufficient to prevent PIN formation. ANG is a secreted protein as the precursor contains a classic signal peptide (49) and it is normally circulating in the plasma. Therefore, ANG could potentially act through an autocrine, a paracrine, or an endocrine manner (50) . The findings that knocking down ANG expression locally in the prostate inhibited AKT-induced rRNA transcription and cell proliferation and prevented PIN formation indicate that ANG functions in a cell autonomous manner. Circulating ANG in the plasma may not have a significant contribution to PIN formation.
Nuclear translocation of ANG is essential for its biological activity (5) . The function of nuclear ANG is to stimulate rRNA transcription by binding to the promoter region of rDNA (47) , and for this to occur, ANG needs to be physically in the nucleus. Neomycin, an aminoglycoside antibiotic, has been shown to block nuclear translocation of ANG in both endothelial cells (4) and prostate cancer cells (8) . Here, we showed that intraperitoneal injection of neomycin blocked nuclear translocation of ANG in the prostate luminal epithelial cells of MPAKT mice, suppressed rRNA transcription in these cells, and prevented PIN formation. These results not only confirmed that ANG plays a role in AKT-mediated prostate cancer but also supported the hypothesis that blocking nuclear translocation of ANG is a therapeutic target for prostate cancer treatment (8) .
ANG is a member of the pancreatic RNase superfamily. Its amino acid sequence has 35% identity and an overall of 56% homology to that of bovine pancreatic RNase A. The ribonucleolytic activity of ANG is several orders of magnitude lower than that of RNase A toward the standard RNase substrates but is essential for its biological activity (32) . Its nature substrate has not been determined but may reside in the nucleolus, as it has been shown that enzymatically inactive mutant ANG proteins undergo nuclear translocation but fail to induce angiogenesis (5) . Screening of 18,310 compounds from the National Cancer Institute Diversity Set and the ChemBridge DIVERSet based on inhibition of the ribonucleolytic activity of ANG has identified N65828 as a lead compound that preferentially inhibited the enzymatic activity of ANG over that of RNase A and prevented xenograft growth of PC-3 human prostate cancer cells in athymic mice (33) . The K i of N65828 toward ANG is 81 Amol/L, a value not good enough for drug development. However, it was a suitable agent in our experiments to show that inhibition of the ribonucleolytic activity of ANG inhibited AKT-induced PIN.
In summary, three different types of ANG inhibitors have been used in this study to ascertain that ANG inhibition inhibits PIN formation and survival. In case of ANG siRNA, a general decrease in ANG expression was observed in the prostate luminal epithelial cells. In neomycin-treated samples, luminal epithelial cells were devoid of nuclear ANG, in agreement with neomycin being a nuclear translocation blocker (8) . Neither expression nor nuclear translocation of ANG was affected by N65828 that only inhibits the enzymatic activity of ANG (33) . In all three cases, rRNA transcription was inhibited without any effect on AKT phosphorylation and its signaling through S6P. Although each of these inhibitors alone may have off-target or nonspecific effect, the findings that three types of ANG inhibitors of different mechanisms all inhibited PIN formation strongly showed that ANG is essential for AKT-driven prostate luminal epithelial cell proliferation and PIN formation in MPAKT mice.
Materials and Methods
Mouse Strains and Genotyping
Animal experiments were approved by Institutional Animal Care and Use Committee of Harvard Medical School. A breeding pair of MPAKT mice was provided by Dr. W.R. Sellers (Dana-Farber Cancer Institute). Genotyping was carried out as described (7) . All the animals were maintained in a pathogen-free barrier facility.
Lentivirus Production
Lentiviral vectors encoding ANG1-specific siRNA or a nonspecific control shRNA were purchased from Open Biosystems. Lentiviral particles were prepared by transient transfection in 293 cells using the ViraPower Lentiviral Expression Systems according to the manufacturer's instruction (Invitrogen). Lentiviral particles were harvested after 72 h, centrifuged at 781 Â g for 15 min, and filtered through a 0.45 Am polyvinylidene fluoride membrane (Millipore). The viral particles were then ultracentrifuged at 83,000 Â g for 1.5 h and the pellet was resuspended in PBS. The functional viral titer was determined by p24 ELISA (ZeptoMetrix) and was expressed as transducing unit per milliliter.
Intraprostate Injection
Five minutes before the surgery, mice were given 1 mL saline subcutaneously and anesthetized with intraperitoneal injection of ketamine and xylazine at 100 and 10 mg/kg body weight, respectively. Mice (4 weeks old) were placed on a sterile gauze covering a heating pad with an ophthalmic ointment placed on their eyes. The abdomen was wiped with betadine followed by 70% ethanol before a middle incision was made through the linea alba. The bladder and seminal vesicle were retracted anteriorly and lentivirus was injected in a 4 AL volume (9 Â 10 6 transducing units) into the ventral lobe of the prostate using a 33-gauge needle with a calibrated push-button dispensing Hamilton syringe. The incision in the fascia was then closed with 3 to 4 silk sutures (6-0) and the skin was closed with auto clips. Mice were given an additional 1 mL saline and 0.05 mg/kg buprenorphine subcutaneously and kept on a heating pad until fully awake. Mice received buprenorphine (0.05 mg/kg) b.i.d. for 3 days post-operation.
Immunohistochemistry
The entire genitourinary tract was removed and fixed with 4% paraformaldehyde and embedded in paraffin. Tissue sections were hydrated, incubated for 30 min with 3% H 2 O 2 in methanol at room temperature, washed with Milli-Q H 2 O and PBS, and heated in a microwave to 95jC in 10 mmol/L citrate buffer (pH 6.0) for 10 min (for ANG, p-S6RP, and Ki-67) or 1 mmol/L EDTA (pH 8.0) for 15 min (for p-AKT). Sections were blocked in 5% dry milk (for mouse ANG) or 10% FBS (for p-AKT and p-S6RP) for 30 min and incubated with antibodies against mouse ANG (10 Ag/mL; R163), p-AKT-S473 (1:100; Cell Signaling), and p-S6RP-S235/236 (1:200; Cell Signaling) in 1% bovine serum albumin at 4jC for 16 h. For detection of Ki-67, the sections were blocked in the M.O.M. mouse immunoglobulin blocking reagent for 60 min and incubated with anti-Ki-67 antibody (1:100; Vector Laboratories) in the M.O.M. diluent at 25jC for 1 h. The slides were washed with PBS, incubated with horseradish peroxidase-labeled second antibody, and visualized with the DakoCytomation EnVision System.
In situ Hybridization
ISH for 47S rRNA was carried out as described by Qian et al. (51) . The templates for the sense riboprobes was prepared by PCR from mouse genomic DNA with sense primer containing a T7 promoter (5 ¶-GGGTAATAGGACTCACTA-TAGGGCGA). The primers for the initiation site of the 47S rRNA precursor were forward 5 ¶-GCCTGTCACTTT-CCTCCCTG and reverse 5 ¶-GCCGAAATAAGGTGGCCCTC; PCR conditions were 5 min at 94jC, 35 cycles (94jC for 1 min, 60jC for 1 min, and 72jC for 1 min), and at 72jC for 7 min. Digoxigenin-labeled probes were generated by in vitro transcription from the above PCR templates using Digoxigenin RNA Labeling Kit (Roche Diagnostics). Formalin-fixed, paraffin-embedded tissue sections were deparaffinized with xylene and rehydrated with ethanol. After proteinase K treatment (1.5 Ag/mL for 10 min at room temperature) and acetylation reaction (0.25% acetic anhydride in 0.1 mmol/L triethanolamine at room temperature for 20 min), the sections were washed with 4Â SSC and prehybridized at 45jC for 1 h in 5Â SSC containing 50% formamide, 0.5 mg/mL heparin, and 0.1 mg/mL salmon sperm DNA. Hybridization was carried out in the same buffer as prehybridization but containing 800 ng/mL digoxigenin-labeled probe at 45jC for 16 h. After successive washing in 4Â SSC (1 min at room temperature), 50% formamide in 2Â SSC (1 h at 45jC), 0.1Â SSC (2 h at 45jC), and Tween 20-TBS (5 min at room temperature), the hybridization signal was visualized using an alkaline phosphatase-conjugated anti-digoxigenin antibody (Roche Applied Science) with nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate as the substrate.
TUNEL Assay
Paraformaldehyde-fixed tissue sections were deparaffinized in xylene, rehydrated in ethanol, and incubated with proteinase K (0.02 mg/mL) for 20 min at room temperature. TUNEL staining was carried out using the Fluorescein-FragEL DNA Fragmentation Detection kit (Calbiochem) per the manufacturer's instructions. TUNEL-positive luminal epithelial cells were counted in all ducts of the ventral prostate.
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